Skip to main content
. 2017 Oct 20;21(3):429–438. doi: 10.1007/s10120-017-0773-y

Table 2.

Post-progression chemotherapy for gastric cancer (placebo plus chemotherapy arm)

Treatment USA/western Europe (n = 81) Eastern Europe/South America (n = 118) Korea and other Asia (n = 94) Japan (n = 94)
Total 30 (37) 17 (14) 57 (61) 72 (77)
 Paclitaxel 3 2 15 52
 Docetaxel 12 2 24 13
 Irinotecan 10 7 22 32
 5-Fluorouracil 14 6 32 18
 S-1 0 0 9 14
 Capecitabine 4 2 2 0
 Methotrexate 0 0 2 12
 Folinic acid 8 5 26 5
 Cisplatin 2 3 10 7
 Oxaliplatin 2 2 17 3

Data are expressed as n (%) or n